Brind.

Entities / Company

Can-Fite BioPharma (Israel).

company in Petah Tikva, Israel

Seen in 27 reportsLast reported May 20

Reports this week: 0
Active events: 0
Connections: 20

What's happening

Gone quiet

No new reports in 90+ days

Can-Fite BioPharma filed a registration statement with the SEC (Bangladesh) and announced a stock offering with HCC acting as the exclusive placement agent.

Some support1 report

Around Can-Fite BioPharma (Israel) this week

News at the entities that move Can-Fite BioPharma (Israel) most

FDA Structural
Generic medicine services are seeking approval for launch from the FDA.

Moves Can-Fite BioPharma (Israel)
Mon 17:49
Securities and Exchange Commission (Bangladesh) Structural
UWM Holdings Corp filed an 8-K with the Securities and Exchange Commission (Bangladesh) on May 13, 2026.

Moves Can-Fite BioPharma (Israel)
Sun 01:13

Connections

The 4 strongest of 20, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.

FDA Structural

Can-Fite BioPharma seeks and receives regulatory designations and approvals from the FDA for its pharmaceutical products.

SpeculativeMay 5

Can-Fite BioPharma (Israel) → FDA
FDA → Can-Fite BioPharma (Israel)
Mash Operational

Can-Fite BioPharma is developing and evaluating Namodenoson as a treatment for the MASH indication.

SpeculativeJun 16

Can-Fite BioPharma (Israel) → Mash
Mash → Can-Fite BioPharma (Israel)
HCC Transactional

HCC functions as the exclusive placement agent for Can-Fite BioPharma's drug Namodenoson.

SpeculativeJul 29

Can-Fite BioPharma (Israel) → HCC
HCC → Can-Fite BioPharma (Israel)
Securities and Exchange Commission (Bangladesh) Structural

Can-Fite BioPharma is subject to the regulatory oversight and filing requirements of the Securities and Exchange Commission of Bangladesh.

SpeculativeJul 29

Can-Fite BioPharma (Israel) → Securities and Exchange Commission (Bangladesh)
Securities and Exchange Commission (Bangladesh) → Can-Fite BioPharma (Israel)

History

Events by the month they began

June 2026

1 event

Jun 8, 2026Can-Fite BioPharma filed a registration statement with the SEC (Bangladesh) and announced a stock offering with HCC acting as the exclusive placement agent.